Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets.
Formation of prostaglandin D2 (PGD2) during the aggregation of platelets was determined, employing a specific bioassay. PGD2 was synthesized in human platelet rich plasma (PRP) in response to thrombin, collagen and epinephrine. Indomethacin pretreatment abolished the biosynthesis of PGD2. When thrombin treated PRP was incubated for different periods of time and denatured in the presence of SnCl2 to prevent the formation of PGD2 from endoperoxides during the extraction procedure, PGD2 formation was noted within the first minute of incubation and reached a peak level after 4 minutes. PGD2 from thrombin stimulated PRP was conclusively identified by gas chromatography-mass spectrometry. The formation of PGD2 during platelet aggregation could represent a mechanism of feedback inhibition of aggregation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001681:Biological Assay; D001792:Blood Platelets / Q000378:metabolism*; D002849:Chromatography, Gas; D003094:Collagen / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D013058:Mass Spectrometry; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis* / Q000097:blood / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D013997:Time Factors
D011453:Prostaglandins; D000244:Adenosine Diphosphate; D003094:Collagen; D013917:Thrombin; D007213:Indomethacin; D004837:Epinephrine